Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
meeting save search
Century Therapeutics Presents New Preclinical Data Highlighting iPSC-derived Cell Therapy Platform Technology at the 2024 American Association for Cancer Research (AACR) Annual Meeting
Published: 2024-04-08 (Crawled : 20:00) - globenewswire.com
IPSC | $3.06 2.86% 2.78% 110K
|
Professional, Scientific, and T...
|
| O: -1.59%
H: 8.87%
C: 7.8%
association cancer cell research preclinical for meeting technology therapeutics therapy platform
Texas Instruments to webcast its 2024 annual meeting of stockholders
Published: 2024-04-08 (Crawled : 18:00) - prnewswire.com
TXN | $159.6 -2.49% -2.55% 10M
|
Electronic Technology
|
| O: 0.07%
H: 1.58%
C: 1.1%
meeting
Merus Presents Preclinical Data Demonstrating Efficacy of Zeno in Cancer Models with High NRG1 Expression at the AACR Annual Meeting 2024
Published: 2024-04-08 (Crawled : 17:00) - globenewswire.com
MRUS | $39.83 -1.58% -1.61% 800K
|
Health Technology
|
| O: 0.0%
H: 0.49%
C: -1.54%
cancer preclinical meeting
Milestone® Pharmaceuticals Announces Etripamil Data Demonstrating Patients’ Ability to Self-Manage Recurring PSVT, Presented at The American College of Cardiology Annual Meeting
Published: 2024-04-08 (Crawled : 15:30) - globenewswire.com
MIST | $1.64 0.61% 0.61% 30K
|
Health Technology
|
| O: 2.78%
H: 0.0%
C: -1.62%
milestone etripamil pharmaceuticals meeting cardiology
Coherus Presents Preclinical Data for CHS-1000, a Novel Anti-ILT4 Antibody, at the 2024 AACR Annual Meeting
Published: 2024-04-08 (Crawled : 12:30) - globenewswire.com
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.77%
H: 1.63%
C: 0.35%
CHRS | $2.06 3.0% 2.91% 2.9M
|
Health Technology
|
| O: 0.82%
H: 3.88%
C: 2.45%
chs-1000 preclinical for meeting
Cargotec corporation: Notice to Annual General Meeting 2024
Published: 2024-04-08 (Crawled : 12:30) - globenewswire.com
FRBA | $12.66 4.46% 4.27% 57K
|
Finance
|
| O: -0.38%
H: 1.23%
C: 0.15%
meeting
ORIC Pharmaceuticals Presents Preclinical Data on Two Programs at the 2024 American Association for Cancer Research (AACR) Annual Meeting
Published: 2024-04-08 (Crawled : 12:00) - globenewswire.com
ORIC | $9.2 -3.26% -3.37% 670K
|
Health Technology
|
| O: -1.25%
H: 0.0%
C: -2.71%
association cancer pharmaceuticals research preclinical for meeting
Theriva™ Biologics Announces Presentation at the American Society for Cell and Gene Therapy 27th Annual Meeting
Published: 2024-04-08 (Crawled : 12:00) - globenewswire.com
TOVX | $0.4152 -7.32% 0.0% 60K
|
Manufacturing
|
| O: 0.62%
H: 2.02%
C: -1.11%
presentation cell for meeting therapy
C4 Therapeutics Presents New Preclinical Data for CFT1946 Highlighting Superior Activity as a Single Agent to Clinically Approved BRAF Inhibitor Standard of Care Combinations at the American Association for Cancer Research Annual Meeting 2024
Published: 2024-04-08 (Crawled : 12:00) - globenewswire.com
CCCC | $6.74 -2.46% -2.52% 1.7M
|
Health Technology
|
| O: -1.57%
H: 0.0%
C: 0.0%
cft1946 association approved cancer care research preclinical for meeting therapeutics
Kymera Therapeutics Announces Scientific Presentations at the American Association for Cancer Research 2024 Annual Meeting
Published: 2024-04-08 (Crawled : 11:00) - globenewswire.com
KYMR | $33.965 -3.29% -3.4% 630K
|
Health Technology
|
| O: 3.38%
H: 0.0%
C: -0.9%
association cancer research for meeting therapeutics
SAB Biotherapeutics to Present at INNODIA Annual Meeting
Published: 2024-04-08 (Crawled : 11:00) - globenewswire.com
SABS | $4.46 0.22% 890
|
|
| O: 4.62%
H: 0.0%
C: -3.09%
meeting
Positive Results from Phase 3 OPTIMIZE-1 Trial of Once Daily OCS-01 for the Treatment of Inflammation and Pain Following Cataract Surgery Presented at the 2024 American Society of Cataract and Refractive Surgery Annual Meeting
Published: 2024-04-08 (Crawled : 11:00) - biospace.com/
OCS | $11.78 0.0% 69K
|
n/a
|
| O: 0.36%
H: 0.18%
C: -2.76%
ocs-01 positive treatment for meeting trial results
SFL - Notice of Annual General Meeting 2024
Published: 2024-04-08 (Crawled : 11:00) - globenewswire.com
SFL | News | $12.71 2.01% 0.0% 540K
|
Transportation
|
| O: -1.19%
H: 0.66%
C: -0.62%
meeting
Weibo to Hold Annual General Meeting on May 22, 2024
Published: 2024-04-08 (Crawled : 10:00) - prnewswire.com
WB | News | $7.9 -1.99% -2.03% 2.2M
|
Technology Services
|
| O: -2.85%
H: 1.69%
C: -0.79%
meeting
Zymeworks Presents New Data from Multiple Preclinical Development Programs at 2024 American Association for Cancer Research Annual Meeting
Published: 2024-04-08 (Crawled : 10:00) - globenewswire.com
ZYME | $8.85 2.08% 2.03% 550K
|
Health Technology
|
| O: 0.0%
H: 1.76%
C: -0.62%
BGNE | $129.51 -1.86% -1.89% 300K
|
Health Technology
|
| O: -0.94%
H: 1.12%
C: 0.61%
association cancer research preclinical for meeting
Innovent to Present Preclinical Data of Multiple Novel Molecules at the 2024 AACR Annual Meeting
Published: 2024-04-08 (Crawled : 00:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 2.24%
H: 0.0%
C: -0.8%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.84%
H: 0.0%
C: 0.0%
preclinical meeting
Black Diamond Therapeutics Presents Novel Real-World Evidence of the Evolving EGFR Mutation Landscape in NSCLC and the Opportunity for BDTX-1535 in an Oral Presentation at the 2024 American Association of Cancer Research Annual Meeting
Published: 2024-04-07 (Crawled : 00:00) - globenewswire.com
BDTX | $5.26 -0.76% -0.76% 390K
|
Health Technology
|
| O: 5.22%
H: 3.44%
C: 2.1%
bdtx-1535 association presentation cancer research for meeting therapeutics
iTeos Presents EOS-984 Preclinical Data Demonstrating Restoration of T Cell Activity from Adenosine Suppression at the American Association for Cancer Research Annual Meeting 2024
Published: 2024-04-07 (Crawled : 00:00) - globenewswire.com
ITOS | $10.58 2.42% 2.36% 940K
|
Health Technology
|
| O: -1.0%
H: 2.26%
C: -1.29%
eos-984 association cancer cell research preclinical for meeting
Interim Results from the ARTACUS Clinical Trial of RP1 Monotherapy in Solid Organ and Hematopoietic Cell Transplant Recipients with Skin Cancers Presented During Oral Presentation at the American Association of Cancer Research (AACR) 2024 Annual Meeting
Published: 2024-04-07 (Crawled : 00:00) - globenewswire.com
REPL | $6.47 -7.17% -7.73% 870K
|
Health Technology
|
| O: 3.27%
H: 0.13%
C: -4.17%
association presentation cancer cell research meeting skin trial results
Shoptalk 2024 Recap: Ulta and Levi’s Invest in Technology to Meet Customer Demand
Published: 2024-04-07 (Crawled : 20:20) - channeladvisor.com
LEVI | $20.55 0.19% 0.0% 1.7M
|
Consumer Non-Durables
|
| O: -0.91%
H: 1.3%
C: -0.77%
technology
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.